Correlation Between Longboard Pharmaceuticals and Orgenesis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Longboard Pharmaceuticals and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longboard Pharmaceuticals and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longboard Pharmaceuticals and Orgenesis, you can compare the effects of market volatilities on Longboard Pharmaceuticals and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longboard Pharmaceuticals with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longboard Pharmaceuticals and Orgenesis.

Diversification Opportunities for Longboard Pharmaceuticals and Orgenesis

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Longboard and Orgenesis is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Longboard Pharmaceuticals and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Longboard Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longboard Pharmaceuticals are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Longboard Pharmaceuticals i.e., Longboard Pharmaceuticals and Orgenesis go up and down completely randomly.

Pair Corralation between Longboard Pharmaceuticals and Orgenesis

If you would invest  5,980  in Longboard Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  18.00  from holding Longboard Pharmaceuticals or generate 0.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy12.5%
ValuesDaily Returns

Longboard Pharmaceuticals  vs.  Orgenesis

 Performance 
       Timeline  
Longboard Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Longboard Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly unfluctuating basic indicators, Longboard Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Orgenesis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Longboard Pharmaceuticals and Orgenesis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Longboard Pharmaceuticals and Orgenesis

The main advantage of trading using opposite Longboard Pharmaceuticals and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longboard Pharmaceuticals position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.
The idea behind Longboard Pharmaceuticals and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements